Total (direct and indirect) public spending on prescription drugs with universal public coverage, all provinces combined, by drug class
| Drug class or condition treated | Actual public spending 2012/13, $ millions | Change in spending, $ millions (% change) | ||
|---|---|---|---|---|
| Base scenario | All model parameters set to worst-case scenario values | All model parameters set to best-case scenario values | ||
| Cholesterol-lowering drugs | 957 | −244 (−26) | 19 (2) | −527 (−55) |
| Antipsychotic agents | 497 | −128 (−26) | 18 (4) | −263 (−53) |
| Diabetes drugs: non-insulin | 414 | −121 (−29) | 0 (0) | −243 (−59) |
| Anticoagulant agents | 199 | −68 (−34) | −22 (−11) | −141 (−70) |
| Pregabalin and gabapentin | 218 | −40 (−18) | 14 (6) | −97 (−44) |
| Osteoporosis | 193 | −28 (−14) | 25 (13) | −101 (−52) |
| Dementia | 190 | −25 (−13) | 30 (16) | −63 (−33) |
| Benign prostatic hypertrophy | 151 | −18 (−12) | 37 (25) | −78 (−52) |
| Hypothyroidism | 102 | −16 (−15) | 75 (74) | −90 (−88) |
| Ocular vascular conditions | 148 | −8 (−5) | 24 (16) | −18 (−12) |
| Antiplatelet therapy | 116 | −6 (−5) | 25 (22) | −52 (−45) |
| Glaucoma | 148 | 1 (0) | 50 (33) | −34 (−23) |
| Antihypertensive agents | 1 392 | 4 (0) | 457 (33) | −433 (−31) |
| Urinary frequency and incontinence | 80 | 10 (12) | 40 (50) | −8 (−10) |
| Androgens | 28 | 18 (64) | 32 (116) | 8 (28) |
| Antidepressants | 668 | 24 (4) | 246 (37) | −209 (−31) |
| Migraines | 59 | 32 (54) | 59 (99) | −5 (−9) |
| Hormone replacement therapy | 82 | 34 (42) | 86 (105) | −9 (−11) |
| Antiretroviral agents for HIV | 286 | 40 (14) | 114 (40) | 15 (5) |
| Acid-reducing drugs | 673 | 51 (8) | 266 (40) | −185 (−27) |
| Opioids | 387 | 55 (14) | 232 (60) | −72 (−19) |
| Diabetes drugs: insulins | 315 | 59 (19) | 174 (55) | 13 (4) |
| Nonsteroidal anti-inflammatory drugs | 221 | 60 (27) | 175 (79) | −69 (−31) |
| ADHD | 146 | 70 (48) | 173 (119) | −14 (−9) |
| Antineoplastic agents | 259 | 84 (32) | 165 (64) | 48 (18) |
| Multiple sclerosis | 196 | 91 (47) | 157 (80) | 70 (36) |
| Benzodiazepines | 145 | 96 (66) | 166 (114) | 12 (9) |
| Respiratory conditions | 815 | 103 (13) | 414 (51) | −51 (−6) |
| Hormonal contraceptives | 126 | 157 (125) | 291 (231) | 62 (49) |
| All other drugs not classified in study | 1 785 | 168 (9) | 922 (52) | −594 (−33) |
| Antibiotic agents | 281 | 173 (61) | 317 (113) | 26 (9) |
| Biologics for inflammatory conditions | 871 | 330 (38) | 605 (69) | 238 (27) |
| Total | 12 151 | 958 (8) | 5 388 (44) | −2 863 (−24) |
Note: ADHD = attention-deficit/hyperactivity disorder.